CDR-Life AG: CDR-Life Announces $76 Million Raised in Series

Proceeds Support Advancement of the M-gager Platform Technology and Lead Product Candidate CDR404, a First Antibody Fragment-based Dual MAGE-A4 T Cell Engager, and Other Discovery ProgramsZÜRICH, Switzerland

Related Keywords

Switzerland , Christian Leisner , Kostenloser Wertpapierhandel , M Gager Platform Technology , Company Board Of Directors , Boehringer Ingelheim , Companym Gager , Proceeds Support Advancement , Lead Product Candidate , First Antibody Fragment Based Dual , Cell Engager , Jeito Capital , Daniel Marks , Claudio Nessi , Managing Director , Omega Funds , Chief Executive Officer , Life , Nnounces , Billion , Aised , Series , Funding ,